Explore the world of PCR-based methods for gene therapy bioanalysis with this three-part interview series with Katherine Veirs, Group Leader for Translational Medicine at QPS Holdings, LLC (DE, USA). Whether you’re interested in technical details, practical applications or regulatory considerations, this series has something for you!

   Sign up here to be the first to know about the next episode!

Technical comparisons between qPCR/dPCR/ddPCR

In the first installment of this three-part series, we caught up with Katherine Veirs to discuss the technical distinctions between qPCR, dPCR and ddPCR, along with their best use ...

Read more

Coming soon: Applications of PCR-based methods in gene therapy development

Part two launching 23 March 2026.  Sign up here to be the first to know about the next episode! Katherine discusses how qPCR, dPCR and ddPCR are being used for vector characterization, ...

Read more

Coming soon: Regulatory considerations, validation strategies and emerging trends

Part three launching 27 April 2026. Sign up here to be the first to know about the next episode! Katherine discusses her approach for developing new PCR-based bioanalytical methods, as ...

Read more

Sponsor